Thu, March 3, 2022
Wed, March 2, 2022
Tue, March 1, 2022
Mon, February 28, 2022
Sun, February 27, 2022
Fri, February 25, 2022

Roanna Ruiz Maintained (AVIR) at Hold with Decreased Target to $9 on, Mar 1st, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -with-decreased-target-to-9-on-mar-1st-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Roanna Ruiz of SVB Leerink, Maintained "Atea Pharmaceuticals, Inc." (AVIR) at Hold with Decreased Target from $10 to $9 on, Mar 1st, 2022.

Roanna has made no other calls on AVIR in the last 4 months.



There is 1 other peer that has a rating on AVIR. Out of the 1 peers that are also analyzing AVIR, 0 agree with Roanna's Rating of Hold.



This is the rating of the analyst that currently disagrees with Roanna


  • Matthew Harrison of "Morgan Stanley" Downgraded from Hold to Sell and Decreased Target to $7 on, Thursday, January 6th, 2022

Publication Contributing Sources